Insmed Launches Brinsupri Tablets in Japan for Bronchiectasis
Insmed launched Brinsupri tablets, 25 mg, in Japan for the treatment of non-cystic fibrosis bronchiectasis.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Insmed launches BRINSUPRI tablets in Japan
Insmed launched BRINSUPRI 25 mg tablets (brensocatib hydrate) for non-cystic fibrosis bronchiectasis in Japan.